2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma
Kaye DR, Wilson LE, Greiner MA, Spees LP, Pritchard JE, Zhang T, Pollack CE, George D, Scales CD, Baggett CD, Gross CP, Leapman MS, Wheeler SB, Dinan MA. Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma. Journal Of Geriatric Oncology 2022, 13: 614-623. PMID: 35125336, PMCID: PMC9232903, DOI: 10.1016/j.jgo.2022.01.008.Peer-Reviewed Original ResearchConceptsMetastatic renal cell carcinomaCancer-specific survivalMedical oncologistsRenal cell carcinomaHospital factorsHospital characteristicsOlder patientsCell carcinomaOAA treatmentDiagnosis of mRCCHigh-quality cancer careOlder adultsDecreased relative riskHigh-poverty zip codesYears of ageAnti-neoplastic agentsMRCC diagnosisSpecialty accessSurvival persistCause mortalityCancer providersPatient factorsMetastatic diagnosisCancer careRelative risk
2015
Otolaryngology utilization of speech‐language pathology services for voice disorders
Cohen SM, Dinan MA, Kim J, Roy N. Otolaryngology utilization of speech‐language pathology services for voice disorders. The Laryngoscope 2015, 126: 906-912. PMID: 26308555, DOI: 10.1002/lary.25574.Peer-Reviewed Original ResearchConceptsLaryngeal/voice disordersSpeech-language pathology servicesSLP evaluationLaryngeal diagnosisDiagnosis changeSLP servicesVoice disordersMultivariable logistic regression analysisPathology servicesClinical Modification codesLogistic regression analysisVoice therapy sessionsPatient ageHealthcare utilizationInitial diagnosisPatient factorsNinth RevisionUnique patientsStudy criteriaVoice-disordered patientsRetrospective analysisStudy populationInternational ClassificationGreater oddsPatients